La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
AMN Healthcare Services Croissance future
Future contrôle des critères 3/6
Le chiffre d'affaires de AMN Healthcare Services devrait diminuer de 0.3% par an tandis que ses bénéfices annuels devraient croître de 26.1% par an. Le BPA devrait croître de de 23.2% par an. Le rendement des capitaux propres devrait être 15.7% dans 3 ans.
Informations clés
26.1%
Taux de croissance des bénéfices
23.2%
Taux de croissance du BPA
Healthcare croissance des bénéfices | 19.4% |
Taux de croissance des recettes | -0.3% |
Rendement futur des capitaux propres | 15.7% |
Couverture par les analystes | Good |
Dernière mise à jour | 16 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
AMN Healthcare Services, Inc.'s (NYSE:AMN) Price Is Right But Growth Is Lacking
Jul 22AMN Healthcare Services (NYSE:AMN) Takes On Some Risk With Its Use Of Debt
Jun 09AMN Healthcare: Trading At An Attractive Valuation For Long-Term Investors
May 29Results: AMN Healthcare Services, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 13AMN Healthcare: Where's The Stopping Point?
Apr 16AMN Healthcare Services, Inc. (NYSE:AMN) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Feb 24The Market Doesn't Like What It Sees From AMN Healthcare Services, Inc.'s (NYSE:AMN) Earnings Yet
Dec 28AMN Healthcare Services (NYSE:AMN) Is Investing Its Capital With Increasing Efficiency
Sep 23AMN Healthcare: Close To Be A 'Buy'
Sep 21AMN Healthcare: Discounted Valuation But Lack Of Growth Makes It Reasonable
Jul 30AMN Healthcare Services (NYSE:AMN) Is Achieving High Returns On Its Capital
Jun 17Here's Why We Think AMN Healthcare Services (NYSE:AMN) Is Well Worth Watching
May 05Returns on Capital Paint A Bright Future For AMN Healthcare Services (NYSE:AMN)
Mar 03AMN Healthcare Q4 results beat estimates, co guides Q1 2023 revenue above consensus
Feb 16Here's Why We Think AMN Healthcare Services (NYSE:AMN) Is Well Worth Watching
Jan 31AMN, Cross Country fall as Jefferies cites lower temp staffing demand
Jan 18Does AMN Healthcare Services (NYSE:AMN) Have A Healthy Balance Sheet?
Jan 04A Look At The Fair Value Of AMN Healthcare Services, Inc. (NYSE:AMN)
Dec 21AMN Healthcare Services a new short idea at Hedgeye
Dec 20AMN Healthcare Services (NYSE:AMN) Could Become A Multi-Bagger
Nov 24AMN Healthcare: Earnings Upside, Return On Capital Key Factors In Investment Debate
Nov 08AMN Healthcare gets new key person
Oct 31Should You Be Adding AMN Healthcare Services (NYSE:AMN) To Your Watchlist Today?
Oct 24These 4 Measures Indicate That AMN Healthcare Services (NYSE:AMN) Is Using Debt Safely
Sep 27AMN Healthcare: Best Covid-19 Period Recoverer And Prospect For Near-Term Capital Gains
Aug 25Shareholders Would Enjoy A Repeat Of AMN Healthcare Services' (NYSE:AMN) Recent Growth In Returns
Aug 15AMN Healthcare Services Non-GAAP EPS of $3.31 beats by $0.32, revenue of $1.43B beats by $60M
Aug 04Estimating The Intrinsic Value Of AMN Healthcare Services, Inc. (NYSE:AMN)
Aug 01With EPS Growth And More, AMN Healthcare Services (NYSE:AMN) Makes An Interesting Case
Jul 19AMN Healthcare Services (NYSE:AMN) Seems To Use Debt Rather Sparingly
Jun 22Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 3,000 | 139 | N/A | N/A | 3 |
12/31/2025 | 2,844 | 59 | 242 | 218 | 9 |
12/31/2024 | 2,909 | 39 | 199 | 277 | 9 |
6/30/2024 | 3,233 | 99 | 205 | 312 | N/A |
3/31/2024 | 3,484 | 144 | 304 | 410 | N/A |
12/31/2023 | 3,789 | 211 | 267 | 372 | N/A |
9/30/2023 | 4,096 | 280 | 430 | 529 | N/A |
6/30/2023 | 4,382 | 319 | 377 | 470 | N/A |
3/31/2023 | 4,817 | 382 | 412 | 497 | N/A |
12/31/2022 | 5,243 | 444 | 573 | 654 | N/A |
9/30/2022 | 5,481 | 478 | 545 | 616 | N/A |
6/30/2022 | 5,220 | 460 | 457 | 519 | N/A |
3/31/2022 | 4,651 | 403 | 411 | 466 | N/A |
12/31/2021 | 3,984 | 327 | 252 | 305 | N/A |
9/30/2021 | 3,252 | 220 | 218 | 267 | N/A |
6/30/2021 | 2,926 | 173 | 298 | 339 | N/A |
3/31/2021 | 2,677 | 128 | 209 | 245 | N/A |
12/31/2020 | 2,394 | 71 | 218 | 257 | N/A |
9/30/2020 | 2,349 | 89 | 256 | 296 | N/A |
6/30/2020 | 2,365 | 86 | 247 | 288 | N/A |
3/31/2020 | 2,292 | 93 | 196 | 240 | N/A |
12/31/2019 | 2,222 | 114 | 188 | 225 | N/A |
9/30/2019 | 2,164 | 122 | 168 | 205 | N/A |
6/30/2019 | 2,123 | 127 | 131 | 166 | N/A |
3/31/2019 | 2,146 | 133 | 165 | 203 | N/A |
12/31/2018 | 2,136 | 142 | 191 | 227 | N/A |
9/30/2018 | 2,117 | 147 | 192 | 226 | N/A |
6/30/2018 | 2,084 | 148 | 184 | 216 | N/A |
3/31/2018 | 2,016 | 143 | N/A | 176 | N/A |
12/31/2017 | 1,988 | 133 | N/A | 161 | N/A |
9/30/2017 | 1,967 | 118 | N/A | 149 | N/A |
6/30/2017 | 1,945 | 117 | N/A | 147 | N/A |
3/31/2017 | 1,929 | 112 | N/A | 141 | N/A |
12/31/2016 | 1,902 | 106 | N/A | 134 | N/A |
9/30/2016 | 1,817 | 100 | N/A | 85 | N/A |
6/30/2016 | 1,727 | 106 | N/A | 78 | N/A |
3/31/2016 | 1,604 | 96 | N/A | 83 | N/A |
12/31/2015 | 1,463 | 82 | N/A | 56 | N/A |
9/30/2015 | 1,340 | 72 | N/A | 61 | N/A |
6/30/2015 | 1,222 | 46 | N/A | 54 | N/A |
3/31/2015 | 1,123 | 38 | N/A | 36 | N/A |
12/31/2014 | 1,036 | 33 | N/A | 28 | N/A |
9/30/2014 | 1,005 | 32 | N/A | 38 | N/A |
6/30/2014 | 998 | 32 | N/A | 50 | N/A |
3/31/2014 | 1,001 | 33 | N/A | 63 | N/A |
12/31/2013 | 1,012 | 33 | N/A | 60 | N/A |
9/30/2013 | 1,011 | 31 | N/A | 63 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de AMN ( 26.1% par an) est supérieure au taux d'épargne ( 2.5% ).
Bénéfices vs marché: Les bénéfices de AMN ( 26.1% par an) devraient croître plus rapidement que le marché US ( 15.1% par an).
Croissance élevée des bénéfices: Les bénéfices de AMN devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Les revenus de AMN devraient diminuer au cours des 3 prochaines années ( -0.3% par an).
Croissance élevée des revenus: Les revenus de AMN devraient diminuer au cours des 3 prochaines années ( -0.3% par an).
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de AMN devrait être faible dans 3 ans ( 15.7 %).